Change of Listing | Oasmia Pharmaceutical AB | 27th August 2019

Due to  Oasmia Pharmaceutical changing listing from NASDAQ to OTC, the following treatment will be applied to the following indices:

  • Oasmia Pharmaceutical AB will be removed from the Index.
  • The weight of Oasmia Pharmaceutical AB based on its last close price will be distributed pro rata to remaining Index constituents.
  • Effective Date (open): 27/08/2019

Solactive US Extended Broad Market Index (GTR)